Finance

Lists
301602:SHE
Shantou Institu of Ultrsnc Instrn Co Ltd
CN¥15,56
-1,39%
(-0,22) 1D
13 Okt., 15:04:28 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301602...
Open
CN¥15,81
High
CN¥15,81
Low
CN¥14,98
Mkt. cap
6,76 mjd
Avg. vol.
3,42 m
Volume
1,81 m
Dividend
0,96%
Quarterly dividend
CN¥0,04
Ex-dividend date
24 Jun. 2026
P/E ratio
61,96
52-wk high
CN¥25,64
52-wk low
CN¥13,40
EPS
CN¥0,25
Shares outstanding
428,33 m
No. of employees
737
Open
CN¥15,81
High
CN¥15,81
Low
CN¥14,98
Mkt. cap
6,76 mjd
Avg. vol.
3,42 m
Volume
1,81 m
Dividend
0,96%
Quarterly dividend
CN¥0,04
Ex-dividend date
24 Jun. 2026
P/E ratio
61,96
52-wk high
CN¥25,64
52-wk low
CN¥13,40
EPS
CN¥0,25
Shares outstanding
428,33 m
No. of employees
737
News stories
From web sources and news partners
Profile
Shantou Institute of Ultrasonic Instruments Co., Ltd is China's biggest manufacturing base of ultrasound with longest history. SIUI goes through a technology development of A-B-C-D-E. Each step has driven the industry progress in China. A: A mode ultrasound equipment. B:B mode ultrasound imaging equipment. C:Color Doppler. In 1997, SIUI manufactured its first color Doppler system Apogee 800.D:Real-time 3D/4D ultrasound. In 2008, SIUI developed the real-time 3D/4D technology, and released a series of real-time 3D/ 4D color Doppler systems. E: Elastography. SIUI develops and manufactures a variety of ultrasound imaging systems and accessories for both human and veterinary use, and NDT equipment including phased-array ultrasonic flaw detector, conventional flaw detector, thickness gauge, probes and accessories. The company is currently organized into three product category divisions: ultrasound imaging systems, medical X-Ray imaging products, and non-destructive testing instruments. SIUI has been certified by ISO9001 Certification, European CE Marking and the U.S. Food and Drug Administration. Wikipedia
About Shantou Institu of Ultrsnc Instrn Co Ltd
CEO-
Employees737
Founded15 Nov. 1982
Headquarters-
SectorMedical device
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
69,93 m
151,90 m
66,33 m
82,68 m
Cost of goods sold
20,10 m
49,56 m
20,19 m
30,11 m
Cost of revenue
20,10 m
49,56 m
20,19 m
30,11 m
Research and development expenses
14,30 m
10,79 m
10,32 m
11,67 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
20,23 m
27,28 m
21,73 m
18,37 m
Operating expense
26,42 m
45,18 m
32,21 m
29,29 m
Total operating expenses
46,52 m
94,74 m
52,40 m
59,40 m
Operating income
23,41 m
57,17 m
13,92 m
23,28 m
Other non operating income
-7,18 m
7,11 m
-10,06 m
9,77 m
EBT including unusual items
22,85 m
69,99 m
10,16 m
21,23 m
EBT excluding unusual items
26,59 m
59,23 m
10,08 m
19,57 m
Income tax expense
2,35 m
10,01 m
1,04 m
3,25 m
Effective tax rate
10,30%
14,30%
10,28%
15,30%
Other operating expenses
-8,09 m
6,04 m
167,40 k
61,92 k
Net income
20,50 m
59,98 m
9,11 m
17,98 m
Net profit margin
29,31%
39,48%
13,74%
21,75%
Earnings per share
-
-
-
-
Interest and investment income
7,79 m
8,23 m
6,22 m
5,34 m
Interest expense
-
-
-
-
Net interest expenses
7,79 m
8,23 m
6,22 m
5,34 m
Depreciation and amortization charges
-
-
-
-
EBITDA
26,00 m
60,00 m
16,76 m
26,34 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme